Due to the high expression of PD-1 on tumor-infiltrating CD8+ T cells, we further evaluated the frequency of PD-1+FcγRIIB+ OT-I T cells in the dLN, spleen, and tumor. This evidence concerns the gene CD8A and neoplasm.